Clinical Trials Logo
  1. Home
  2. Chronic Cluster Headache
  3. NCT05868044

REsponse to Combined SONS and ONS in Chronic Cluster headachE — RESPONSE  

Chronic Cluster Headache Clinical Trial

Official title:
REsponse to Combined SuPra-orbital and Occipital Nerve Stimulation in Chronic Cluster headachE With the PRIMUS System, a First in Human Study

Clinical Trial Summary

The purpose of this study is to demonstrate the safe use of a novel cranio-facial Peripheral Nerve Stimulator PNS System in subjects with chronic cluster headache. This is a single-centre, open label, prospective, first in human study to collect initial clinical data on the PNS System for the treatment of chronic cluster headache.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05868044
Study type Interventional
Source Salvia BioElectronics
Contact Wim Pollet, MD
Phone +32 498 57 98 98
Email wim.pollet@salvianeuro.com
Status Recruiting
Phase N/A
Start date May 2, 2023
Completion date April 30, 2026
View Details
See also
  Status Clinical Trial Phase
Completed NCT02462395 - Anodal Transcranial Direct Stimulation (tDCS) for the Treatment of Chronic Cluster Headache Phase 2/Phase 3
Completed NCT05064397 - A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH) Phase 3
Recruiting NCT01701245 - Prevention and Acute Treatment of Chronic Cluster Headache Compared to Standard of Care Phase 2
Completed NCT01151631 - Occipital Nerve Stimulation in Medically Intractable Chronic Cluster Headache Phase 3
Recruiting NCT06124534 - Bilateral Occipital Nerve Field Stimulation for the Treatment of dtCCH N/A
Unknown status NCT00399243 - Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache Phase 4
Completed NCT01616511 - Pathway CH-1 Long-Term Follow-Up N/A
Completed NCT01359631 - Cephalic Vascular Recording Upon SPG Stimulation N/A
Completed NCT02438826 - A Study of Galcanezumab in Participants With Chronic Cluster Headache Phase 3
Completed NCT02510729 - SPG Neurostimulation in Cluster Patients N/A
Active, not recruiting NCT02168764 - Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache N/A
Completed NCT02797951 - A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache Phase 3
Not yet recruiting NCT05477459 - LSD to Improve Cluster Headache Impact Trial Phase 2
Completed NCT03244735 - Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache: a Prospective Case Series N/A
Terminated NCT02964338 - A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH) Phase 3
Completed NCT01255813 - Sphenopalatine Ganglion Stimulation for the Acute Treatment of Cluster Headache N/A
Active, not recruiting NCT05023460 - Treatment of Chronic Cluster Headache With TENS and ONS N/A